Pharmaceutical economics and policy

Generic drugs the pay-for-delay problem /
Wydane: (2011)

CAPA for the FDA-regulated industry /
od: Rodríguez Pérez, José, 1961-
Wydane: (2010)

Profits before people? ethical standards and the marketing of prescription drugs /
od: Weber, Leonard J., 1942-
Wydane: (2006)

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
od: Cook, Arthur G.
Wydane: (2006)

Pharmaceutical reform a guide to improving performance and equity /
od: Roberts, Marc J.
Wydane: (2011)

Pharmaceutical blending and mixing /
Wydane: (2015)

Continuous processing in pharmaceutical manufacturing /
Wydane: (2015)

Measuring transparency to improve good governance in the public pharmaceutical sector.
Wydane: (2009)

Measuring transparency to improve good governance in the public pharmaceutical sector.
Wydane: (2009)

Medicines as a service a new commercial model for big pharma in the postblockbuster world /
od: Mattke, Soeren
Wydane: (2012)

Pharmaceutical project management
Wydane: (2008)

The pharmaceutical studies reader /
Wydane: (2015)

Threats and opportunities for European pharmaceutical wholesalers in a changing healthcare environment
od: Cmolik, Andreas
Wydane: (2012)

Manufacturing of pharmaceutical proteins : from technology to economy /
od: Behme, Stefan
Wydane: (2015)

Pharmaceutical residues in freshwater : hazards and policy responses /
Wydane: (2019)

Crystallization of organic compounds an industrial perspective /
od: Tung, Hsien-Hsin, 1955-
Wydane: (2009)

Risk management applications in pharmaceutical and biopharmaceutical manufacturing
Wydane: (2013)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Wydane: (2004)

Glocal pharma : international brands and the imagination of local masculinity /
od: Johnson, Ericka
Wydane: (2016)

A practical approach to pharmaceutical policy
od: Seiter, Andreas
Wydane: (2010)

Handbook of pharmaceutical biotechnology
Wydane: (2007)

Pharmaceutical microbiology
od: Kar, Ashutosh
Wydane: (2008)

The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
Wydane: (2006)

Pharmaceutical biotechnology drug discovery and clinical applications /
Wydane: (2012)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
od: Willig, Sidney H., 1919-
Wydane: (2000)

Hugo and Russell's pharmaceutical microbiology
Wydane: (2004)

Hugo and Russell's pharmaceutical microbiology
Wydane: (2011)

Extractables & Leachables for Pharmaceutical Products 2011 : [conference proceedings] : Dublin, Ireland, 27-28 September 2011 /
Wydane: (2011)

Cracking the code understand and profit from the biostech revolution that will transform our lives and generate fortunes /
od: Mellon, Jim
Wydane: (2012)

Pharmaceutical biotechnology
od: Sambamurthy, K.
Wydane: (2006)

An investigation of the effect of healthcare policy change on sales and strategies of anti-malarial pharmaceutical companies in Kenya /
od: Nyaoke, Lorraine M.
Wydane: (2009)

Devalued and distrusted can the pharmaceutical industry restore its broken image? /
od: LaMattina, John L.
Wydane: (2013)

Shaping the industrial century the remarkable story of the modern chemical and pharmaceutical industries /
od: Chandler, Alfred D. (Alfred Dupont), 1918-2007
Wydane: (2005)

Pharmaceutical industry innovation and developments /
Wydane: (2011)

Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
Wydane: (2007)

The risks of prescription drugs
Wydane: (2010)